Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pioglitazone Compared to a Combination Therapy With Ramipril and to a Ramipril Monotherapy on Low Grade Inflammation and Vascular Function in Patients With Increased Cardiovascular Risk and an Activated Inflammation. A Randomized Double-blinded Phase II Study.

NCT00770497 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00770497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pioglitazone Compared to a Combination Therapy With Ramipril and to a Ramipril Monotherapy on Low Grade Inflammation and Vascular Function in Patients With Increased Cardiovascular Risk and an Activated Inflammation. A Randomized Double-blinded Phase II Study.
Lead sponsor
Takeda
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2007
Completion date
May 31, 2008
Enrollment
172 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, inflammation